WebChiesi Hellas SA 14 years 4 months Region Manager Chiesi Hellas SA May 2016 - Present6 years 6 months Thessaloniki Area Manager Chiesi Hellas SA May 2012 - May 20164 years 1 month... WebΣήμερα, η Chiesi Hellas έχοντας ήδη αυξήσει το προσωπικό της και τις πωλήσεις της, είναι μία σωστά οργανωμένη εταιρεία, με δυναμική παρουσία στην Ελληνική Φαρμακευτική αγορά, με υψηλούς ρυθμούς ανάπτυξης που αποτελούν σοβαρή παρακαταθήκη για ένα ακόμα καλύτερο μέλλον. Σταύρος Γ. Θεοδωράκης Πρόεδρος & Διευθύνων Σύμβουλος
PRESS RELEASES - chiesi.uk.com
WebChiesi Hellas 2,865 followers on LinkedIn. People & Ideas for Innovation in Healthcare Headquartered in Parma since 1935, Chiesi is an international company with more than 85 years of experience and a strong focus on research, development, production and the commercialization of innovative medicines in the Respiratory, Neonatology, Rare … WebChiesi Hellas S.A. is located in Alimos, Greece. 4K+ Wholesalers, Manufacturers and Product distributors. M: +30 21 0617 9763, DM, WhatsApp. Pharmaceutical Bank nelft southend
Chiesi Hellas Alimos - Facebook
WebDoing Business As: CHIESI HELLAS S.A. Company Description: Key Principal: Stavros George Theodorakis See more contacts Industry: Drugs, proprietaries, and sundries … WebChiesi USA is a specialty pharmaceutical company focused on developing and promoting products for the hospital, adjacent specialty and rare disease markets. Celebrating over 80 years of bringing innovative products to the global healthcare marketplace, we are a proud affiliate of Chiesi Farmaceutici S.p.A. Web08-11-2024. Chiesi Global Rare Diseases Announces Approval of FERRIPROX® (deferiprone) in Canada for the Treatment of Iron Overload in Sickle Cell Disease. 15-10-2024. Protalix Biotherapeutics and Chiesi Global Rare Diseases Announce Final Dosing of Last Patient in Phase III BALANCE Clinical Trial PRX-102 for the Treatment of Fabry … itom maturity model